Pfizer CEO Albert Bourla unpacks the impact of the nomination on 'The Claman Countdown.' ...

Pfizer’s chief executive said he was “disappointed” with Robert F Kennedy Jr’s refusal to disavow the debunked link between vaccines and autism, even as he expressed confidence that the Trump ...

CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing ...

Still, Trump looks to be using tariff announcements "primarily as a negotiating tool" and this could help the euro to recover ...

President Trump’s chief cost-cutter cheered an effort to persuade federal workers to quit — in a fashion that closely ...

A Semafor analysis of government schedules showed little access for business executives, a freeze-out expected to reverse ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

There was a sense of guarded optimism in the air at the latest World Economic Forum. But CEOs want their CCOs to step up and deliver on their greater accountability.

“If you fail to understand the playing field that Trump is playing on, it will be hard to understand his vision,” Milei told Bloomberg Editor-in-Chief John Micklethwait on Wednesday in Bloomberg House ...

Among the executive order's directives, companies were required to report details of their technology to federal regulators. Separately, Doctors Without Borders, physicians, and industry top brass ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.